Precision Oncology and Cancer Biomarkers: Issues at Stake and Matters of Concern

This open-access book explores the social and ethical implications of precision oncology, addressing bioethical dilemmas, scientific challenges, and economic trade-offs. It takes a broad actor-centered perspective, raising questions about the experiences of patients, clinicians, and policymakers.

Format: Paperback / softback
Length: 281 pages
Publication date: 29 March 2022
Publisher: Springer Nature Switzerland AG

This open-access book explores the social and ethical implications of precision oncology, delving into the experiences, concerns, and challenges faced by individuals working in and around this field. Each chapter examines the diverse perspectives and experiences of those involved in precision oncology, including cancer researchers, clinicians, policymakers, patients, and social workers. It also discusses and analyzes bioethical dilemmas, scientific challenges, and economic trade-offs associated with precision oncology. The book adopts a broad actor-centered perspective, recognizing that the range of actors with issues at stake in cancer is vast. This approach fosters in-depth and diverse questions, posed by the actors themselves, such as how cancer researchers navigate biological uncertainties, how clinicians and policymakers address ethical dilemmas related to care prioritization, how patients experience precision oncology, and how policymakers and entrepreneurs envision precision oncology.

This book is of significant interest to a wide audience, including cancer researchers, oncologists, policymakers, medical ethicists, philosophers, social scientists, patients, and health economists. It provides valuable insights into the complex and evolving landscape of precision oncology and offers valuable perspectives and insights for those engaged in this field.

Weight: 456g
Dimension: 235 x 155 (mm)
ISBN-13: 9783030926144
Edition number: 1st ed. 2022